Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Hypertension Awareness Campaign Has $25 Mil. Ad Spend

Executive Summary

Novartis is launching an "integrated" hypertension disease awareness campaign to encourage earlier and more aggressive treatment of high blood pressure, Pharmaceuticals CEO Thomas Ebeling said April 22

You may also be interested in...



Novartis Unbranded Hypertension Ad Cited For Link To Diovan Promotion

Novartis has had two conference calls with FDA's Division of Drug Marketing, Advertising & Communications to discuss the agency's concerns about unbranded ads connected with the company's direct-to-consumer Diovan (valsartan) campaign

Novartis Unbranded Hypertension Ad Cited For Link To Diovan Promotion

Novartis has had two conference calls with FDA's Division of Drug Marketing, Advertising & Communications to discuss the agency's concerns about unbranded ads connected with the company's direct-to-consumer Diovan (valsartan) campaign

Novartis Launches Hypertension Awareness Program With Support From HHS

Novartis has the support of HHS and the Centers for Medicare & Medicaid Services for its hypertension disease awareness campaign

Latest News
See All
UsernamePublicRestriction

Register

PS043828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel